Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lymphopenia 1Esophageal Neoplasms 1

Interventions

Specimen Handling 189Magnetic Resonance Spectroscopy 150pembrolizumab 147Carboplatin 110Biopsy 106Cyclophosphamide 92Cisplatin 85Paclitaxel 76Bevacizumab 68Gemcitabine 67Nivolumab 59fludarabine 56Fluorouracil 52Radiotherapy 49Capecitabine 49Pemetrexed 45Dexamethasone 45Oxaliplatin 44Rituximab 43Leucovorin 43atezolizumab 42Docetaxel 41venetoclax 39Doxorubicin 39durvalumab 37Temozolomide 32Standard of Care 32Radiation 32Prednisone 32Cetuximab 31

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × SARS-CoV-2 inactivated vaccines × 30 days × Clear all
NCT06181656 2026-05-20

Serologic Response to Pneumococcal Vaccination Among Esophageal Cancer Patients With High Grade Lymphopenia After Chemoradiation

M.D. Anderson Cancer Center

Recruiting
80 enrolled
Gastrointestinal

Esophageal Neoplasms, Lymphopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡